Covidien Urges 1st Circ. To Reconsider Ex-Exec's Patent Win

Law360 (April 23, 2021, 7:14 PM EDT) -- Covidien LP has asked the full First Circuit to rehear a case that affirmed Covidien had no rights to three varicose vein treatment patents filed by a former top executive, arguing that the panel relied on an incorrect interpretation of the jury verdict.

In a petition filed Thursday, Medtronic unit Covidien argued that a three-judge panel got it wrong earlier this month when it backed a Massachusetts federal judge's decision not to award Covidien rights to any inventions that would stem from a group of patents Brady Esch applied for after leaving his job as the company's head of global strategic...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!